Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
YC: Conceptualization, Writing review and editing
Drugs like Eliquis (apixaban, patents expiring 2026-2028) and Entresto (sacubitril/valsartan, facing competition as early as 2025) represent molecules with massive patient populations and correspondingly large savings opportunity once generics enter
The retatrutide trials reported a small number of pancreatic events, consistent with the class effect seen in tirzepatide and semaglutide studies
They're manufactured in labs to either mimic natural peptides or create novel compounds with specific effects
Current brand-name prices range from $300 to $570 monthly across different pharmacy chains and provinces
in the year ending in February 2023, according to the FDA
US$ 23.95
US$ 29.93
US$ 24.73
US$ 24.13
US$ 28.19
